These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9057400

  • 1. Clinical and enzyme studies in Gaucher disease.
    Kaur M, Kabra M, Kher A, Naik G, Bharucha BA, Verma IC.
    Indian Pediatr; 1996 Sep; 33(9):735-8. PubMed ID: 9057400
    [Abstract] [Full Text] [Related]

  • 2. Gaucher's disease. I. Modern enzymatic and anatomic methods of diagnosis.
    Lee RE, Robinson DB, Glew RH.
    Arch Pathol Lab Med; 1981 Feb; 105(2):102-4. PubMed ID: 6779779
    [Abstract] [Full Text] [Related]

  • 3. Heterozygote detection of type I Gaucher disease using blood platelets.
    Nakagawa S, Kumin S, Sachs G, Nitowsky HM.
    Prog Clin Biol Res; 1982 Feb; 95():597-602. PubMed ID: 6812088
    [No Abstract] [Full Text] [Related]

  • 4. Gaucher type I (Ashkenazi) disease: considerations for heterozygote detection and prenatal diagnosis.
    Grabowski GA, Dinur T, Gatt S, Desnick RJ.
    Prog Clin Biol Res; 1982 Feb; 95():573-95. PubMed ID: 6812087
    [No Abstract] [Full Text] [Related]

  • 5. [A case of adult Gaucher disease].
    Werling K, Lengyel G, Vallent K, Zalatnai A, Burger M, Laky J.
    Orv Hetil; 1992 Oct 11; 133(41):2631-4. PubMed ID: 1408099
    [Abstract] [Full Text] [Related]

  • 6. Gaucher disease: accurate identification of asymptomatic French-Canadian carrier using nonlabeled authentic sphingolipid substrate N-palmitoyl dihydroglucocerebroside.
    Choy FY, Bouillon L, Laurin CA.
    Am J Med Genet; 1987 Aug 11; 27(4):895-905. PubMed ID: 3425599
    [Abstract] [Full Text] [Related]

  • 7. Clinical consequences of interrupting enzyme replacement therapy in children with type 1 Gaucher disease.
    Drelichman G, Ponce E, Basack N, Freigeiro D, Aversa L, Graciela E, Kohan R.
    J Pediatr; 2007 Aug 11; 151(2):197-201. PubMed ID: 17643778
    [Abstract] [Full Text] [Related]

  • 8. The clinical and demographic characteristics of nonneuronopathic Gaucher disease in 887 children at diagnosis.
    Kaplan P, Andersson HC, Kacena KA, Yee JD.
    Arch Pediatr Adolesc Med; 2006 Jun 11; 160(6):603-8. PubMed ID: 16754822
    [Abstract] [Full Text] [Related]

  • 9. Clinical variation in 2 related children with neuronopathic Gaucher disease.
    Grover WD, Tucker SH, Wenger DA.
    Ann Neurol; 1978 Mar 11; 3(3):281-3. PubMed ID: 96723
    [Abstract] [Full Text] [Related]

  • 10. [Gaucher disease: diagnosis and treatment].
    Fumić K, Stavljenić-Rukavina A, Mrsić M, Potocki K.
    Acta Med Croatica; 2004 Mar 11; 58(5):353-8. PubMed ID: 15756799
    [Abstract] [Full Text] [Related]

  • 11. [Biochemical and genetic diagnosis of Gaucher disease and its phenotypical heterogeneity].
    Beĭer EM, Bukina TM, Tsvetkova IV.
    Vopr Med Khim; 2000 Mar 11; 46(5):451-4. PubMed ID: 11204625
    [Abstract] [Full Text] [Related]

  • 12. Phenotypic manifestations of Gaucher disease: clinical features in 48 biochemically verified type 1 patients and comment on type 2 patients.
    Kolodny EH, Ullman MD, Mankin HJ, Raghavan SS, Topol J, Sullivan JL.
    Prog Clin Biol Res; 1982 Mar 11; 95():33-65. PubMed ID: 6289358
    [No Abstract] [Full Text] [Related]

  • 13. Sodium taurocholate effect on beta-glucosidase activity: a new approach for identification of Gaucher disease using the synthetic substrate and leucocytes.
    Magalhães J, Sá Miranda MC, Pinto R, Lemos M, Poenaru L.
    Clin Chim Acta; 1984 Aug 31; 141(2-3):111-8. PubMed ID: 6435915
    [Abstract] [Full Text] [Related]

  • 14. [Gaucher's disease. Longitudinal-study in 17 patients in a 10-year period (1970-1980) (author's transl)].
    Di Rocco M, Salemi D, Borrone C.
    Pediatr Med Chir; 1981 Aug 31; 3(6):487-94. PubMed ID: 7343946
    [Abstract] [Full Text] [Related]

  • 15. [Enzyme replacement therapy for Gaucher disease introduced in late adulthood].
    Juhász P, Tóth B, Maródi L, Erdos M.
    Orv Hetil; 2012 Feb 19; 153(7):264-70. PubMed ID: 22318527
    [Abstract] [Full Text] [Related]

  • 16. Type 1 Gaucher disease presenting with extensive mandibular lytic lesions: identification and expression of a novel acid beta-glucosidase mutation.
    Wasserstein MP, Martignetti JA, Zeitlin R, Lumerman H, Solomon M, Grace ME, Desnick RJ.
    Am J Med Genet; 1999 Jun 04; 84(4):334-9. PubMed ID: 10340647
    [Abstract] [Full Text] [Related]

  • 17. [The possibility of increasing the precision of biochemical diagnostics of Gaucher disease].
    Horovenko NH, Drozdova VD, Nedoboĭ AM, Ol'khovych NV, Pichkur NO, Tsyhankova MA, Radzikhovs'ka OV.
    Tsitol Genet; 2006 Jun 04; 40(3):67-71. PubMed ID: 16933855
    [Abstract] [Full Text] [Related]

  • 18. [Laboratory diagnosis of lysosomal storage disease (glycoproteinosis Pompe's disease and Gaucher disease)].
    Shi HP, Zhang GX, Guo YF, Fang BL, Zhang WM, Chen F, Luo HY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Dec 04; 7(6):475-7. PubMed ID: 2940012
    [No Abstract] [Full Text] [Related]

  • 19. [Gaucher disease type I diagnosed at 63 years old presenting with thrombocytopenia].
    Kawahara S, Kato A, Oshimi K, Ida H.
    Rinsho Ketsueki; 2008 May 04; 49(5):335-9. PubMed ID: 18572811
    [Abstract] [Full Text] [Related]

  • 20. Non-neuronopathic Gaucher disease due to saposin C deficiency.
    Tylki-Szymańska A, Czartoryska B, Vanier MT, Poorthuis BJ, Groener JA, Ługowska A, Millat G, Vaccaro AM, Jurkiewicz E.
    Clin Genet; 2007 Dec 04; 72(6):538-42. PubMed ID: 17919309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.